硕肯生物硕肯生物Soken.bio
查看试用产品 →开放浏览 · 登录后申请
人 C-Reactive Protein 抗体对
试剂盒

人 C-Reactive Protein 抗体对

01AB02147

C-reactive protein (C-Reactive Protein) is a pentameric acute‑phase protein (pentraxin family) encoded by the CRP gene on chromosome 1, synthesized mainly by hepatocytes in response to interleukin‑6 and other cytokines, and widely used as a sensitive biomarker of systemic inflammation. It binds phosphocholine on microbial surfaces and damaged cells, activating complement and opsonization, thus linking innate immunity to clearance of pathogens and necrotic debris. High‑sensitivity CRP (hsCRP) assays quantify low‑grade inflammation relevant to cardiometabolic disease risk. Persistently elevated CRP is associated with increased risk of coronary artery disease, stroke, and peripheral artery disease, and may correlate more strongly with fatal than nonfatal coronary events. Elevated CRP also tracks with obesity, insulin resistance, metabolic syndrome, and type 2 diabetes, and common CRP and IL6 locus variants influence baseline CRP levels and cardiovascular risk. Chronic CRP elevation further associates with neurodegenerative and other chronic inflammatory diseases.

Human
规格起售价
登录后可查看

技术参数

靶点基因名
CRP
基因别名
PTX1
蛋白别名
C-reactive protein; C-Reactive Protein
UniProt
P02741
物种
Human

产品详情

靶点名称
C-Reactive Protein
蛋白名称
C-reactive protein
蛋白别名
C-reactive protein [Cleaved into: C-reactive protein(1-205]
靶点基因名
CRP
基因别名
PTX1
UniProt
P02741
来源物种
Homo sapiens (Human)
物种反应性
Human

背景介绍

C-reactive protein (C-Reactive Protein) is a pentameric acute‑phase protein (pentraxin family) encoded by the CRP gene on chromosome 1, synthesized mainly by hepatocytes in response to interleukin‑6 and other cytokines, and widely used as a sensitive biomarker of systemic inflammation. It binds phosphocholine on microbial surfaces and damaged cells, activating complement and opsonization, thus linking innate immunity to clearance of pathogens and necrotic debris. High‑sensitivity CRP (hsCRP) assays quantify low‑grade inflammation relevant to cardiometabolic disease risk. Persistently elevated CRP is associated with increased risk of coronary artery disease, stroke, and peripheral artery disease, and may correlate more strongly with fatal than nonfatal coronary events. Elevated CRP also tracks with obesity, insulin resistance, metabolic syndrome, and type 2 diabetes, and common CRP and IL6 locus variants influence baseline CRP levels and cardiovascular risk. Chronic CRP elevation further associates with neurodegenerative and other chronic inflammatory diseases.